LivaNova (LIVN) Competitors $47.44 -0.55 (-1.15%) Closing price 04:00 PM EasternExtended Trading$47.44 +0.01 (+0.01%) As of 04:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends LIVN vs. PEN, GKOS, STVN, BLCO, INSP, NARI, NVST, PRCT, IRTC, and WRBYShould you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Penumbra (PEN), Glaukos (GKOS), Stevanato Group (STVN), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), Envista (NVST), PROCEPT BioRobotics (PRCT), iRhythm Technologies (IRTC), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry. LivaNova vs. Penumbra Glaukos Stevanato Group Bausch + Lomb Inspire Medical Systems Inari Medical Envista PROCEPT BioRobotics iRhythm Technologies Warby Parker Penumbra (NYSE:PEN) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, community ranking, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations. Which has more volatility and risk, PEN or LIVN? Penumbra has a beta of 0.53, suggesting that its stock price is 47% less volatile than the S&P 500. Comparatively, LivaNova has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500. Does the MarketBeat Community believe in PEN or LIVN? Penumbra received 431 more outperform votes than LivaNova when rated by MarketBeat users. Likewise, 80.33% of users gave Penumbra an outperform vote while only 69.58% of users gave LivaNova an outperform vote. CompanyUnderperformOutperformPenumbraOutperform Votes82980.33% Underperform Votes20319.67%LivaNovaOutperform Votes39869.58% Underperform Votes17430.42% Do analysts rate PEN or LIVN? Penumbra presently has a consensus price target of $292.64, indicating a potential downside of 0.04%. LivaNova has a consensus price target of $69.17, indicating a potential upside of 45.63%. Given LivaNova's stronger consensus rating and higher possible upside, analysts clearly believe LivaNova is more favorable than Penumbra.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Penumbra 0 Sell rating(s) 3 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.88LivaNova 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has preferable valuation and earnings, PEN or LIVN? Penumbra has higher revenue and earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPenumbra$1.19B9.44$90.95M$0.34861.09LivaNova$1.15B2.24$17.55M$0.42113.08 Is PEN or LIVN more profitable? LivaNova has a net margin of 1.91% compared to Penumbra's net margin of 1.17%. LivaNova's return on equity of 13.81% beat Penumbra's return on equity.Company Net Margins Return on Equity Return on Assets Penumbra1.17% 9.74% 7.35% LivaNova 1.91%13.81%7.07% Does the media refer more to PEN or LIVN? In the previous week, Penumbra had 55 more articles in the media than LivaNova. MarketBeat recorded 61 mentions for Penumbra and 6 mentions for LivaNova. Penumbra's average media sentiment score of 0.66 beat LivaNova's score of 0.62 indicating that Penumbra is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 16 Very Positive mention(s) 9 Positive mention(s) 19 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive LivaNova 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in PEN or LIVN? 88.9% of Penumbra shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 5.0% of Penumbra shares are owned by insiders. Comparatively, 0.3% of LivaNova shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryPenumbra beats LivaNova on 11 of the 18 factors compared between the two stocks. Get LivaNova News Delivered to You Automatically Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIVN vs. The Competition Export to ExcelMetricLivaNovaElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.58B$3.42B$5.81B$9.02BDividend YieldN/A1.65%4.78%3.85%P/E Ratio113.0816.1326.2318.96Price / Sales2.2461.02453.4377.29Price / Cash11.0445.9944.0437.47Price / Book2.003.897.664.69Net Income$17.55M$92.00M$3.18B$245.69M7 Day Performance-0.39%-1.73%-1.36%-1.85%1 Month Performance-3.49%0.15%0.73%-1.54%1 Year Performance-16.41%10.80%17.60%14.60% LivaNova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIVNLivaNova3.5803 of 5 stars$47.44-1.1%$69.17+45.8%-8.8%$2.58B$1.15B112.952,900Upcoming EarningsPENPenumbra4.459 of 5 stars$267.83-1.9%$261.36-2.4%+12.7%$10.28B$1.06B311.434,200Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGKOSGlaukos4.399 of 5 stars$153.06+4.6%$151.08-1.3%+71.4%$8.44B$314.71M-50.68780Earnings ReportAnalyst UpgradeInsider TradeNews CoverageGap DownSTVNStevanato Group1.236 of 5 stars€19.49+2.2%N/A-32.5%$5.90B$1.17B41.475,635Positive NewsBLCOBausch + Lomb3.7366 of 5 stars$16.44-1.2%$20.25+23.2%+9.1%$5.79B$4.15B-15.6513,300Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageINSPInspire Medical Systems4.8316 of 5 stars$184.73-1.3%$228.82+23.9%-7.0%$5.54B$624.80M172.651,011Insider TradeNARIInari Medical1.6759 of 5 stars$79.93flat$68.00-14.9%+37.6%$4.68B$493.63M-59.211,300NVSTEnvista3.5382 of 5 stars$21.59+0.3%$20.21-6.4%-6.5%$3.71B$2.51B-3.3312,800PRCTPROCEPT BioRobotics3.2681 of 5 stars$67.61-2.4%$97.86+44.7%+33.5%$3.53B$199.84M-34.67430Positive NewsIRTCiRhythm Technologies1.0045 of 5 stars$112.11-0.1%$108.45-3.3%+0.2%$3.51B$492.68M-23.072,000Earnings ReportAnalyst ForecastNews CoverageGap UpWRBYWarby Parker2.5457 of 5 stars$25.70-2.7%$21.77-15.3%+80.0%$2.61B$669.77M-95.193,491Upcoming EarningsAnalyst ForecastGap Up Related Companies and Tools Related Companies PEN Alternatives GKOS Alternatives STVN Alternatives BLCO Alternatives INSP Alternatives NARI Alternatives NVST Alternatives PRCT Alternatives IRTC Alternatives WRBY Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LIVN) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LivaNova PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share LivaNova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
